» Articles » PMID: 16508761

Acute Dose of MDMA (75 Mg) Impairs Spatial Memory for Location but Leaves Contextual Processing of Visuospatial Information Unaffected

Overview
Specialty Pharmacology
Date 2006 Mar 2
PMID 16508761
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Research concerning spatial memory in 3,4-methylenedioxymethamphetamine (MDMA) users has presented conflicting results showing either the presence or absence of spatial memory deficits. Two factors may have confounded results in abstinent users: memory task characteristics and polydrug use.

Objectives: The present study aims to assess whether a single dose of MDMA affects spatial memory performance during intoxication and withdrawal phase and whether spatial memory performance after MDMA is task dependent.

Materials And Methods: Eighteen recreational MDMA users participated in a double-blind, placebo-controlled, three-way crossover design. They were treated with placebo, MDMA 75 mg, and methylphenidate 20 mg. Memory tests were conducted between 1.5 and 2 h (intoxication phase) and between 25.5 and 26 h (withdrawal phase) post-dosing. Two spatial memory tasks of varying complexity were used that required either storage of stimulus location alone (spatial memory task) or memory for location as well as processing of content or contextual information (change blindness task).

Results: After a single dose of MDMA, the subjects made larger localization errors and responded faster compared to placebo in the simple spatial memory task during intoxication phase. Inaccuracy was not due to increased response speed, as determined by regression analysis. Performance in the change blindness task was not affected by MDMA. Methylphenidate did not affect performance on any of the tasks.

Conclusion: It is concluded that a single dose of MDMA impairs spatial memory for location but leaves processing of contextual information intact.

Citing Articles

A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects.

Adam A, LaMalfa K, Razavi Y, Kohut S, Kangas B Psychedelic Med (New Rochelle). 2024; 2(2):96-108.

PMID: 39149579 PMC: 11324000. DOI: 10.1089/psymed.2023.0049.


Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.

Basedow L, Majic T, Hafiz N, Algharably E, Kreutz R, Riemer T Sci Rep. 2024; 14(1):14782.

PMID: 38926480 PMC: 11208433. DOI: 10.1038/s41598-024-65391-9.


A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.

Velit-Salazar M, Shiroma P, Cherian E Brain Sci. 2024; 14(3).

PMID: 38539636 PMC: 10968220. DOI: 10.3390/brainsci14030248.


A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.

Sessa B, Higbed L, Nutt D Front Psychiatry. 2019; 10:138.

PMID: 30949077 PMC: 6435835. DOI: 10.3389/fpsyt.2019.00138.


3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.

Otalora G M, Grigsby J, Poulter B, Van Derveer 3rd J, Giron S, Jerome L J Psychopharmacol. 2018; 32(12):1295-1307.

PMID: 30371148 PMC: 6247454. DOI: 10.1177/0269881118806297.


References
1.
Verkes R, Gijsman H, Pieters M, Schoemaker R, de Visser S, Kuijpers M . Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berl). 2001; 153(2):196-202. DOI: 10.1007/s002130000563. View

2.
Morgan M . Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology. 1998; 19(4):252-64. DOI: 10.1016/S0893-133X(98)00012-8. View

3.
Morford L, Gudelsky G, Williams M, Vorhees C . Impaired spatial and sequential learning in rats treated neonatally with D-fenfluramine. Eur J Neurosci. 2002; 16(3):491-500. DOI: 10.1046/j.1460-9568.2002.02100.x. View

4.
Semple D, Ebmeier K, Glabus M, OCarroll R, Johnstone E . Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry. 2000; 175:63-9. DOI: 10.1192/bjp.175.1.63. View

5.
Wareing M, Fisk J, Murphy P, Montgomery C . Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy'). Hum Psychopharmacol. 2005; 20(2):115-23. DOI: 10.1002/hup.670. View